OverviewSuggest Edit

PacBio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. The Company provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges.

TypePublic
Founded2004
HQMenlo Park, US
Websitepacb.com

Latest Updates

Employees (est.) (Dec 2018)401(-12%)
Revenue (FY, 2018)$78.6 M(-15%)
Share Price (Nov 2019)$4.7 (-1%)

Pacific Biosciences of California Office Locations

Pacific Biosciences of California has offices in Menlo Park and Irvine
Menlo Park, US (HQ)
1380 Willow Rd
Irvine, US
4143 Health Sciences Rd
Show all (2)

Pacific Biosciences of California Financials and Metrics

Pacific Biosciences of California Revenue

Embed Graph
View revenue for all periods
Pacific Biosciences of California's revenue was reported to be $78.63 m in FY, 2018
USD

Revenue (Q3, 2019)

21.9m

Gross profit (Q3, 2019)

6.9m

Gross profit margin (Q3, 2019), %

31.5%

Net income (Q3, 2019)

(29.1m)

EBIT (Q3, 2019)

(28.1m)

Market capitalization (15-Nov-2019)

714.7m

Closing stock price (15-Nov-2019)

4.7

Cash (30-Sep-2019)

33.1m

EV

755.6m
Pacific Biosciences of California's current market capitalization is $714.7 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

33.9m26.0m28.2m60.6m92.8m90.7m93.5m78.6m

Revenue growth, %

115%53%(2%)

Cost of goods sold

20.8m25.0m21.8m37.2m39.3m46.6m58.8m53.5m

Gross profit

13.0m940.0k6.4m23.4m53.5m44.2m34.7m25.1m
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

58.9m46.5m26.4m36.4m33.6m16.8m16.5m18.8m

Accounts Receivable

4.6m2.8m2.7m3.4m5.2m11.4m13.4m8.6m

Prepaid Expenses

2.1m2.0m1.1m1.7m12.1m2.2m2.8m

Inventories

15.5m9.6m10.1m11.3m11.0m15.6m23.1m17.9m
USDY, 2019

EV/EBIT

-26.9 x

EV/CFO

-12.6 x

Financial Leverage

2.9 x
Show all financial metrics

Pacific Biosciences of California Operating Metrics

FY, 2016

Patents (Foreign)

133

Patents (US)

221

Patents Pending

187
Show all operating metrics

Pacific Biosciences of California Revenue Breakdown

Embed Graph

Pacific Biosciences of California revenue breakdown by geographic segment: 56.0% from North America, 22.1% from Europe and 21.9% from Asia

Pacific Biosciences of California Online and Social Media Presence

Embed Graph

Pacific Biosciences of California News and Updates

Pacific Biosciences of California, Inc. Announces First Quarter 2019 Financial Results

MENLO PARK, Calif., May 03, 2019 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2019, as attached.

Global DNA Sequencing Products Markets Report 2011-2018 & 2019-2024 Featuring Illumina, Thermo Fisher Scientific, Roche Diagnostics, Pacific Biosciences of California & Beckman Coulter

DUBLIN, Feb. 27, 2019 /PRNewswire/ -- The "DNA Sequencing Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering. The global DNA sequencing products market was worth around US$ 4 Billion...

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Pacific Biosciences of California, Inc. - PACB

NEW YORK, Dec. 6, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating the Board of Directors of Pacific Biosciences of California, Inc....

Pacific Biosciences of California, Inc. Third Quarter 2018 Financial Results Call

MENLO PARK, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2018 Financial Results on Thursday, November 1, 2018, at 4:30pm Eastern Time.

Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock

MENLO PARK, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.  Pacific Biosciences also intends to grant the underwriters a 30-day option…

Pacific Biosciences of California Blogs

Webinar Summary: Need accurate isoform-level characterization? Iso-Seq is the answer

PacBio Principal Scientist Elizabeth Tseng and PacBio user Gloria Sheynkman described the Iso-Seq RNA Sequencing method and how it is used at the Dana-Farber Cancer Institute in this recent webinar.

At ASHG Workshop, Customers Describe Long-Read Sequencing of Human Genomes for Disease Gene Discovery and Population Studies

Videos and highlights from PacBio's educational workshop at the 2019 ASHG meeting, featuring talks from two customers as well as an overview of SMRT Sequencing.

Mapping the NLRome: Research Teams Turn to SMRT Sequencing to Trace Plant Immunity

There’s the genome, the transcriptome, the microbiome… and now the NLRome?  Two research teams have successfully created inventories of NLR genes in plants by combining resistance gene enrichment sequencing (RenSeq) with SMRT Sequencing.

Double Mutations in Oncogene May Improve Patient Response to Targeted Therapy

A new paper in Science reports completely novel findings about compound mutations in the PIK3CA oncogene that are associated with patients who respond extremely well to targeted therapies. While more studies are needed, this work has important implications for delivering treatment to patients with b…

Finding the Females: New Reference Genome Leads to Better Sex Determination Technique in Tuna

A team of Japanese researchers has used a new Pacific bluefin tuna reference genome to identify male-specific DNA markers in the fish.

ASHG 2019: CoLab Session Highlights Structural Variation and Transcriptome Sequencing

At ASHG, PacBio scientists presented how our Sequel II System performs for structural variant detection and whole transcriptome sequencing.
Show more

Pacific Biosciences of California Frequently Asked Questions

  • When was Pacific Biosciences of California founded?

    Pacific Biosciences of California was founded in 2004.

  • How many employees does Pacific Biosciences of California have?

    Pacific Biosciences of California has 401 employees.

  • What is Pacific Biosciences of California revenue?

    Latest Pacific Biosciences of California annual revenue is $78.6 m.

  • What is Pacific Biosciences of California revenue per employee?

    Latest Pacific Biosciences of California revenue per employee is $196.1 k.

  • Who are Pacific Biosciences of California competitors?

    Competitors of Pacific Biosciences of California include Oxford Nanopore Technologies, GNS Healthcare and TriZetto.

  • Where is Pacific Biosciences of California headquarters?

    Pacific Biosciences of California headquarters is located at 1380 Willow Rd, Menlo Park.

  • Where are Pacific Biosciences of California offices?

    Pacific Biosciences of California has offices in Menlo Park and Irvine.

  • How many offices does Pacific Biosciences of California have?

    Pacific Biosciences of California has 2 offices.